Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy Study on Deoxyspergualin (NKT-01) in Patients With Uncontrolled Lupus Nephritis Receiving Oral Corticosteroids and Prior Treatment of Standard Immunosuppressive Therapy

NCT00709722 is registered in ClinicalTrials.gov with Nippon Kayaku Co., Ltd. as lead sponsor.

NCT NCT00709722
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00709722 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy Study on Deoxyspergualin (NKT-01) in Patients With Uncontrolled Lupus Nephritis Receiving Oral Corticosteroids and Prior Treatment of Standard Immunosuppressive Therapy
Lead sponsor
Nippon Kayaku Co., Ltd.
Phase
Phase 1/2
Overall status
Completed
Start date
October 31, 2003
Completion date
April 30, 2007
Enrollment
21 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

lupus nephritis